By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MadisonyMadisony
Notification Show More
Font ResizerAa
  • Home
  • National & World
  • Politics
  • Investigative Reports
  • Education
  • Health
  • Entertainment
  • Technology
  • Sports
  • Money
  • Pets & Animals
Reading: UBS Turns Extra Bullish on Gilead Sciences, Inc. (GILD) Amid Constructive Pharma Sector Outlook
Share
Font ResizerAa
MadisonyMadisony
Search
  • Home
  • National & World
  • Politics
  • Investigative Reports
  • Education
  • Health
  • Entertainment
  • Technology
  • Sports
  • Money
  • Pets & Animals
Have an existing account? Sign In
Follow US
2025 © Madisony.com. All Rights Reserved.
Money

UBS Turns Extra Bullish on Gilead Sciences, Inc. (GILD) Amid Constructive Pharma Sector Outlook

Madisony
Last updated: February 2, 2026 2:40 am
Madisony
Share
UBS Turns Extra Bullish on Gilead Sciences, Inc. (GILD) Amid Constructive Pharma Sector Outlook
SHARE


Gilead Sciences, Inc. (NASDAQ:GILD) is among the many most worthwhile healthcare shares to purchase. On January 26, UBS lifted the value goal on Gilead Sciences, Inc. (NASDAQ:GILD) from $145 to $155 and maintained a Purchase score, in line with TheFly. Barely beneath the consensus 1-year excessive value goal, the revised goal implies almost 12% upside.

From interesting valuations and lightweight positioning to supporting drug-pricing overhangs and sustained pharma-led M&A exercise, there are numerous causes to consider within the robust efficiency of the U.S. Prescription drugs and Biotechnology group, the analyst famous. UBS famous that though there are worries concerning the conservative steerage, notably after the latest rally, cheap valuations for giant pharma and biotech are anticipated to proceed constructive cash flows into the sector.

Copyright: dolgachov / 123RF Inventory Picture

On the identical day, BMO Capital additionally raised its goal on Gilead Sciences, Inc. (NASDAQ:GILD) to $150 from $135 and reiterated an Outperform score on the inventory. Whereas highlighting the Yeztugo launch, which achieved $150 million in FY25 gross sales, the agency cited robust momentum within the firm’s HIV enterprise.

​Gilead Sciences, Inc. (NASDAQ:GILD) is a California-based biopharmaceutical firm specializing in medicines aimed toward unmet wants. Based in 1987, the corporate supplies a variety of merchandise as options for HIV/AIDS, COVID-19, viral hepatitis, oncology, pulmonary arterial hypertension, and critical invasive fungal infections.

Whereas we acknowledge the potential of GILD as an funding, we consider sure AI shares provide better upside potential and carry much less draw back threat. When you’re searching for an especially undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the greatest short-term AI inventory.

READ NEXT: The Greatest and Worst Dow Shares for the Subsequent 12 Months and 10 Unstoppable Shares That Might Double Your Cash.

Disclosure: None.

Subscribe to Our Newsletter
Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Share This Article
Email Copy Link Print
Previous Article Tremendous Bowl 2026: Information that would fall when Patriots battle Seahawks Tremendous Bowl 2026: Information that would fall when Patriots battle Seahawks
Next Article Olivia Dean takes dwelling greatest new artist Grammy Olivia Dean takes dwelling greatest new artist Grammy

POPULAR

Restaurant Manufacturers Worldwide (QSR) This fall 2025 earnings
Money

Restaurant Manufacturers Worldwide (QSR) This fall 2025 earnings

Mum’s Loud Toy Boy Affair Shocks Son, Plus Sex Secrets and Lazy Kids
world

Mum’s Loud Toy Boy Affair Shocks Son, Plus Sex Secrets and Lazy Kids

AT&T Pebble Seaside Professional-Am odds, predictions, props: PGA Tour picks, greatest prop bets from confirmed from golf mannequin
Sports

AT&T Pebble Seaside Professional-Am odds, predictions, props: PGA Tour picks, greatest prop bets from confirmed from golf mannequin

1/7: The Takeout with Main Garrett
National & World

1/7: The Takeout with Main Garrett

Voluntary departures hit document excessive as detained immigrants lose hope of getting launched or profitable in court docket
Politics

Voluntary departures hit document excessive as detained immigrants lose hope of getting launched or profitable in court docket

Many Adjustable Mattress Frames Have a “Zero Gravity” Characteristic. I Tried It for a Week
Technology

Many Adjustable Mattress Frames Have a “Zero Gravity” Characteristic. I Tried It for a Week

Senate, Home search probes into alleged Philippine-based operations in Epstein recordsdata
Investigative Reports

Senate, Home search probes into alleged Philippine-based operations in Epstein recordsdata

You Might Also Like

Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Outcome
Money

Analyst Confidence Upbeat on Shattuck Labs (STTK) Amid SL-325 Progress and Earlier Q3 2025 Outcome

With robust three-month efficiency and important upside potential, Shattuck Labs, Inc. (NASDAQ:STTK) secures a spot on our checklist of the…

3 Min Read
Shoppers flash vacation warning indicators
Money

Shoppers flash vacation warning indicators

Customers stroll by means of Manhattan on Nov. 7, 2025, in New York Metropolis.Spencer Platt | Getty PhotosExcessive-income customers are…

20 Min Read
Chocolate Halloween sweet hit by inflation, tariffs, excessive cocoa costs
Money

Chocolate Halloween sweet hit by inflation, tariffs, excessive cocoa costs

A buyer retailers for Halloween sweet at a Walmart Supercenter on October 16, 2024 in Austin, Texas. Brandon Bell | Getty…

8 Min Read
Greatest high-yield financial savings rates of interest as we speak, January 4, 2026 (Earn as much as 4% APY)
Money

Greatest high-yield financial savings rates of interest as we speak, January 4, 2026 (Earn as much as 4% APY)

Learn the way a lot you may earn with as we speak’s financial savings charges. Rates of interest on financial…

4 Min Read
Madisony

We cover the stories that shape the world, from breaking global headlines to the insights behind them. Our mission is simple: deliver news you can rely on, fast and fact-checked.

Recent News

Restaurant Manufacturers Worldwide (QSR) This fall 2025 earnings
Restaurant Manufacturers Worldwide (QSR) This fall 2025 earnings
February 12, 2026
Mum’s Loud Toy Boy Affair Shocks Son, Plus Sex Secrets and Lazy Kids
Mum’s Loud Toy Boy Affair Shocks Son, Plus Sex Secrets and Lazy Kids
February 12, 2026
AT&T Pebble Seaside Professional-Am odds, predictions, props: PGA Tour picks, greatest prop bets from confirmed from golf mannequin
AT&T Pebble Seaside Professional-Am odds, predictions, props: PGA Tour picks, greatest prop bets from confirmed from golf mannequin
February 12, 2026

Trending News

Restaurant Manufacturers Worldwide (QSR) This fall 2025 earnings
Mum’s Loud Toy Boy Affair Shocks Son, Plus Sex Secrets and Lazy Kids
AT&T Pebble Seaside Professional-Am odds, predictions, props: PGA Tour picks, greatest prop bets from confirmed from golf mannequin
1/7: The Takeout with Main Garrett
Voluntary departures hit document excessive as detained immigrants lose hope of getting launched or profitable in court docket
  • About Us
  • Privacy Policy
  • Terms Of Service
Reading: UBS Turns Extra Bullish on Gilead Sciences, Inc. (GILD) Amid Constructive Pharma Sector Outlook
Share

2025 © Madisony.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?